Ansseau M, Doumont A, Cerfontaine J L, Sulon J, Demey-Ponsart E, Geenen V, Legros J J
Psychoneuroendocrinology. 1985;10(2):215-9. doi: 10.1016/0306-4530(85)90060-5.
The performance of the dexamethasone suppression test (DST) in the diagnostic confirmation of endogenous depression was compared according to two times of blood collection--1600 hr on day 2 (usual sample) and 0800 hr on day 3 (34 hr after dexamethasone intake)--in 14 endogenous depressives and in a control group of 17 psychiatric inpatients with other diagnoses. For the day 2 (1600 hr) sample, a 5 micrograms/dl cortisol concentration represented the best cut-off score, with sensitivity of 57% specificity of 88%, and diagnostic confidence of 80%. For the day 3 (0800 hr) sample, the best cut-off score was 20 micrograms/dl, with the same sensitivity (57%) but there was a decrease of both specificity (to 76%) and diagnostic confidence (to 67%). The mean cortisol levels were much higher on day 3 than on day 2, suggesting that the inhibitory activity of dexamethasone was no longer present.
根据两次采血情况,对14名内源性抑郁症患者以及17名患有其他诊断的精神科住院患者组成的对照组,比较了地塞米松抑制试验(DST)在内源性抑郁症诊断确认中的表现。两次采血时间分别为第2天的16:00(常规样本)和第3天的08:00(服用地塞米松34小时后)。对于第2天(16:00)的样本,皮质醇浓度5微克/分升代表最佳临界值,敏感性为57%,特异性为88%,诊断可信度为80%。对于第3天(08:00)的样本,最佳临界值为20微克/分升,敏感性相同(57%),但特异性(降至76%)和诊断可信度(降至67%)均有所下降。第3天的平均皮质醇水平远高于第2天,表明地塞米松的抑制活性已不存在。